Pancreatic Cancer

Our patients with pancreatic cancer are cared for in a multidisciplinary clinic to coordinate, simplify and combine multiple appointments. Our collaborative team coordinates patient care creating personalized therapy plans.

Experts at Fred Hutchinson Cancer Research Center and UW Medicine have identified new ways to prevent, detect early, diagnose and treat pancreatic cancer. Researchers discovered genetic mutations that define targets for screening, early diagnosis and new treatment strategies that include enzyme/chemotherapy combinations and immunotherapy.


We have integrated a multi-dimensional program across UW MedicineSeattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center for translation with its own administrative structure – the Center for Accelerated Translation in Pancreas Cancer (CATPAC). The components of CATPAC include population sciences, high-risk disease, preclinical and clinical trials.

A focal point of CATPAC is the Pancreas Cancer Specialty Clinic (PCSC), a real-time multi-disciplinary clinic in which patients receive a same-day comprehensive evaluation and care plan from a team of specialists including surgical oncology, medical oncology, radiation oncology, gastroenterology, body imaging (radiology), pathology, nursing, symptom management and palliative care, pharmacy, nutrition, social work, and staff focused on spiritual needs.  

We have developed genetically accurate models of cancer that mimic the human disease. These models have been used to develop and test novel therapeutic strategies with pancreas cancer. Some of these drugs are in clinical trials available here.

Dr. Suni Hingorani
STTR Pancreas Cancer Deputy Director

Dr. Hingorani is a medical oncologist who specializes in the care of pancreas cancer patients. He also runs a translational research program dedicated to uncovering mechanisms of pancreas cancer formation and developing new early detection and treatment strategies. His laboratory research involves the study of molecular and cellular origins of pancreas cancer primarily through the use of genetically engineered mouse models.

Learn more at the Hingorani Lab